|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn893672000 |
003 |
OCoLC |
005 |
20231120111825.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
141024s1975 enkaf ob 101 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d E7B
|d N$T
|d OCL
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d YDXCP
|d UAB
|d OCLCA
|d OCLCQ
|d VLY
|d LUN
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 948744323
|a 1162231124
|
020 |
|
|
|a 9781483159577
|q (electronic bk.)
|
020 |
|
|
|a 1483159574
|q (electronic bk.)
|
020 |
|
|
|z 0080182429
|
020 |
|
|
|z 9780080182421
|
035 |
|
|
|a (OCoLC)893672000
|z (OCoLC)948744323
|z (OCoLC)1162231124
|
050 |
|
4 |
|a RC514
|b .S847 1973eb
|
060 |
|
4 |
|a WM 203
|b S987c 1975
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.8/98
|2 23
|
084 |
|
|
|a 44.91
|2 bcl
|
111 |
2 |
|
|a Symposium on Catecholamines
|n (3rd :
|d 1973 :
|c Strasbourg, France)
|
245 |
1 |
0 |
|a Catecholamines and schizophrenia :
|b [proceedings of the third international Symposium on Catecholamines, Strasbourg, France, May 18-21, 1973] /
|c edited by Steven W. Matthysse, Ph. D., and Seymour S. Kety, M.D., Harvard University School of Medicine and Massachusetts General Hospital, Boston.
|
250 |
|
|
|a First edition.
|
264 |
|
1 |
|a Oxford :
|b Pergamon Press,
|c 1975.
|
300 |
|
|
|a 1 online resource (xix, 369 pages, 6 unnumbered leaves of plates) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
504 |
|
|
|a Includes bibliographical references and index.
|
500 |
|
|
|a Originally published as v. 11 of the Journal of psychiatric research.
|
520 |
|
|
|a Catecholamines and Schizophrenia reviews research linking catecholamines to schizophrenia. Topics include the relationship between stereotyped behavior and amphetamine psychosis, between antipsychotic drugs and catecholamine synapses, and between biogenic amines and behavior. The chemical neuropathology of schizophrenia, enzymology and regulation of catecholamine enzymes, and advances in histochemical technologies used in neurochemical pathology are also covered.
|
505 |
0 |
|
|a Front Cover; Catecholamines and Schizophrenia; Copyright Page; ACKNOWLEDGEMENTS; Table of Contents; PROLOGUE; EPILOGUE; CONTRIBUTORS; Chapter 1. PHARMACOLOGY AND PHYSIOLOGY OF STEREOTYPED BEHAVIOR; PSYCHOLOGY OF STEREOTYPED BEHAVIOR; BRAIN DOPAMINE AND STEREOTYPED BEHAVIOR; RELATION OF STEREOTYPED BEHAVIOR AND BRAIN DOPAMINE TO SCHIZOPHRENIA, MANIA AND DEPRESSION; REFERENCES; DISCUSSION; Chapter 2. AMPHETAMINE PSYCHOSIS: BEHAVIORAL AND BIOCHEMICAL ASPECTS; INTRODUCTION; BEHAVIORAL ASPECTS-HOSPITALIZED CASES; BEHAVIORAL ASPECTS-EXPERIMENTALLY-INDUCED CASES; BIOCHEMICAL ASPECTS
|
505 |
8 |
|
|a CATECHOLAMINE METABOLITES IN CEREBROSPINAL FLUID AFTER AMPHETAMINE ADMINISTRATIONBEHAVIOURAL AND BIOCHEMICAL EFFECTS OF l-DOPA ADMINISTRATION IN PSYCHIATRIC PATIENTS; ANTAGONISM OF AMPHETAMINE-INDUCED SYMPTOMS BY HALOPERIDOL; CONCLUSION; REFERENCES; Chapter 3. A TWO FACTOR THEORY OF SCHIZOPHRENIA; DISCUSSION; REFERENCES; Chapter 4. STEREOSELECTIVE FEATURES OF CATECHOLAMINE DISPOSTION AND THEIR BEHAVIORAL IMPLICATIONS; BIOCHEMICAL STUDIES OF STEREOSELECTIVE CATECHOLAMINE DISPOSITION; BEHAVIORAL IMPLICATIONS; SUMMARY; REFERENCES
|
505 |
8 |
|
|a Chapter 8. DOSE EQUIVALENCE OF THE ANTIPSYCHOTIC DRUGSREFERENCES; BRIEF COMMUNICATIONS; Chapter 9. MASS FRAGMENTOMETRIC DETERMINATION OF HOMOVANILLIC ACID IN LUMBAR CEREBROSPINAL FLUID OF SCHIZOPHRENICPATIENTS DURING TREATMENTWITH ANTIPSYCHOTIC DRUGS; REFERENCES; Chapter 10. NEW DEVELOPMENTS IN THE STUDY OF THE MECHANISM OF ACTION OF NEUROLEPTICS AND AMPHETAMINE; 1. CORTICAL DOPAMINERGIC TERMINALS; 2. DECREASED SYNTHESIS OF DOPAMINE IN THE NEOSTRIATUM OF THE RAT AFTER A REPEATED TREATMENT WITH A NEUROLEPTIC; 3. STUDIES ON DOPAMINE RELEASE IN A CHRONIC MONKEY PREPARATION; REFERENCES
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Schizophrenia
|v Congresses.
|
650 |
|
0 |
|a Catecholamines
|v Congresses.
|
650 |
|
0 |
|a Catecholamines.
|
650 |
|
0 |
|a Schizophrenia.
|
650 |
|
2 |
|a Catecholamines
|0 (DNLM)D002395
|
650 |
|
2 |
|a Schizophrenia
|0 (DNLM)D012559
|
650 |
|
6 |
|a Schizophr�enie
|0 (CaQQLa)201-0020959
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Cat�echolamines
|0 (CaQQLa)201-0021822
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Cat�echolamines.
|0 (CaQQLa)201-0021822
|
650 |
|
6 |
|a Schizophr�enie.
|0 (CaQQLa)201-0020959
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Catecholamines
|2 fast
|0 (OCoLC)fst00848987
|
650 |
|
7 |
|a Schizophrenia
|2 fast
|0 (OCoLC)fst01106752
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Matthysse, Steven,
|e editor.
|
700 |
1 |
|
|a Kety, Seymour S.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|a Symposium on Catecholamines (3rd : 1973 : Strasbourg).
|t Catecholamines and schizophrenia.
|b First edition
|z 0080182429
|w (DLC) 75004093
|w (OCoLC)2523171
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780080182421
|z Texto completo
|